Condition
Post-Traumatic Neuralgia
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 3 (2)
Trial Status
Completed2
Unknown2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06071988Phase 3Unknown
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
NCT06071936Phase 3Unknown
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
NCT04876989Not ApplicableCompleted
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block
NCT03253523Not ApplicableWithdrawnPrimary
Post-traumatic Occipital Neuralgia - Surgical Versus Medical Management
NCT03447756Phase 1Completed
Titration Study of ABX-1431
Showing all 5 trials